Lingfeng He

Jiangsu Key Laboratory For Molecular And Medical Biotechnology
Nanjing, 210023, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 56 publications

Next-Generation CAR-T Therapies: From Personalized Anticancer Drugs to Broadly Applicable Disease-Modifying Treatments.

Next-Generation CAR-T Therapies: From Personalized Anticancer Drugs to Broadly Applicable Disease-Modifying Treatments.

Journal: Transplantation and cellular therapy

Published: April 03, 2026

CAR-T cell therapy for autoimmune diseases: from immune suppression to immune resetting.

CAR-T cell therapy for autoimmune diseases: from immune suppression to immune resetting.

Journal: International immunopharmacology

Published: March 26, 2026

Erythrocyte membrane-liposome coating sustains circulation stability and targeted tumor therapy of CAR-T cells.

Erythrocyte membrane-liposome coating sustains circulation stability and targeted tumor therapy of CAR-T cells.

Journal: Frontiers in immunology

Published: January 29, 2026

Barriers and Strategies to Enhance CAR-T Cell Infiltration in Solid Tumours: A Systematic Review.

Barriers and Strategies to Enhance CAR-T Cell Infiltration in Solid Tumours: A Systematic Review.

Journal: Immunology

Published: September 11, 2025

Sodium valproate drives propionylation-mediated epigenetic reprogramming to enhance mesothelin CAR-T cell therapy in solid tumors.

Sodium valproate drives propionylation-mediated epigenetic reprogramming to enhance mesothelin CAR-T cell therapy in solid tumors.

Journal: Molecular therapy : the journal of the American Society of Gene Therapy

Published: August 26, 2025

CCR2/CXCR6 enhances tumor infiltration and antitumor efficacy of MSLN CAR-T cells.

CCR2/CXCR6 enhances tumor infiltration and antitumor efficacy of MSLN CAR-T cells.

Journal: Cellular and molecular life sciences : CMLS

Published: July 24, 2025

Microbiota-derived butyrate potentiates MSLN CAR-T cell therapy by metabolic reprogramming and extracellular matrix remodeling.

Microbiota-derived butyrate potentiates MSLN CAR-T cell therapy by metabolic reprogramming and extracellular matrix remodeling.

Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie

Published: June 17, 2025

Glutamine-driven metabolic reprogramming promotes CAR-T cell function through mTOR-SREBP2 mediated HMGCS1 upregulation in ovarian cancer.

Glutamine-driven metabolic reprogramming promotes CAR-T cell function through mTOR-SREBP2 mediated HMGCS1 upregulation in ovarian cancer.

Journal: Journal of translational medicine

Published: May 04, 2025

APE1 inhibition-promoted pyroptosis triggers T-cell infiltration and enhances anti-tumor immunity in NSCLC.

APE1 inhibition-promoted pyroptosis triggers T-cell infiltration and enhances anti-tumor immunity in NSCLC.

Journal: Genes & diseases

Published: March 10, 2025

P4HB, a novel succinated protein, is essential for fumarate-induced cancer metastasis.

P4HB, a novel succinated protein, is essential for fumarate-induced cancer metastasis.

Journal: International journal of biological macromolecules

Published: January 03, 2025

Sodium citrate pretreatment enhances CAR-T cell persistence and anti-tumor efficacy through inhibition of calcium signaling.

Sodium citrate pretreatment enhances CAR-T cell persistence and anti-tumor efficacy through inhibition of calcium signaling.

Journal: Frontiers in immunology

Published: December 06, 2024

A self-activated and protective module enhances the preclinical performance of allogeneic anti-CD70 CAR-T cells.

A self-activated and protective module enhances the preclinical performance of allogeneic anti-CD70 CAR-T cells.

Journal: Frontiers in immunology

Published: November 20, 2024

Showing 1-12 of 56

Last Updated: 09/26/2026